Mechanism of nitroglycerin-induced hypoxemia

Area of Science:

• Cardiology
• Pulmonary Medicine
• Pharmacology

Background:

• Sublingual nitroglycerin consistently reduces arterial oxygen tension (PaO2) in various patient groups.
• The exact mechanism behind this PaO2 reduction remains under investigation.

Purpose of the Study:

• To investigate the mechanism responsible for the decrease in PaO2 following sublingual nitroglycerin administration.
• To determine if pulmonary vasodilatation or altered shunt fraction is the primary cause of nitroglycerin-induced hypoxemia.

Main Methods:

• Administered nitroglycerin with and without phenylephrine (a pulmonary vasoconstrictor) in patients with coronary artery disease.
• Measured systemic and pulmonary hemodynamics, including PaO2, arterial pressures, and cardiac index.
• Quantified intrapulmonary right-to-left shunt fraction before and after nitroglycerin in a subset of patients.

Main Results:

• Nitroglycerin administration led to significant decreases in PaO2, mean systemic arterial pressure, pulmonary arterial pressure, pulmonary arterial occlusive pressure, and cardiac index.
• Co-administration of phenylephrine prevented the decline in PaO2, suggesting a role for pulmonary vasodilation.
• The increase in intrapulmonary shunt fraction after nitroglycerin was minimal and insufficient to explain the observed PaO2 reduction.

Conclusions:

• The reduction in PaO2 after sublingual nitroglycerin is primarily caused by pulmonary vasodilatation.
• This vasodilation leads to increased perfusion of poorly ventilated lung units, resulting in relative hypoxemia.
• Nitroglycerin's effect on hypoxic pulmonary vasoconstriction or shunt fraction is not the predominant mechanism for hypoxemia.